Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Maria Y. Ho"'
Autor:
Eva Grunfeld, Jennifer T. Chang, Carolyn C. Gotay, Jenny Y. Ruan, Maria Y. Ho, Sharon Relova, Winson Y. Cheung, Craig C. Earle, Miranda Tsonis, Mary L. McBride
Publikováno v:
Psycho-Oncology. 25:1470-1476
Background Prior survivorship research has largely focused on issues faced by survivors of childhood tumors, breast cancers, or hematologic malignancies. Relatively little is known about the needs of other prevalent survivor groups. Our aim was to id
Publikováno v:
Journal of Gastrointestinal Cancer. 45:487-493
Surgical resection plays an integral part in the curative treatment of esophageal (EC) and gastric cancer (GC). The impact of the allocation of surgeons at the county level on these cancer outcomes is unclear. Our aims were to examine the effect of s
Publikováno v:
Journal of gastrointestinal cancer. 47(4)
We aimed to explore the effect of county-level general surgeon (GS) and colorectal surgeon (CS) density on colorectal cancer (CRC) mortality and to identify additional county characteristics associated with outcomes.Using data from the Area Resource
Publikováno v:
Journal of Gastrointestinal Cancer. 43:239-242
Autor:
Maria Y. Ho, Winson Y. Cheung
Publikováno v:
Journal of Cancer Therapy. :977-984
The number of long-term colorectal cancer (CRC) survivors has increased substantially over the past three decades due to both ongoing advances in early detection and improvements in cancer therapies. Adult survivors of CRC experience chronic health c
Autor:
Maria Y, Ho, Mary L, McBride, Carolyn, Gotay, Eva, Grunfeld, Craig C, Earle, Sharon, Relova, Miranda, Tsonis, Jenny Y, Ruan, Jennifer T, Chang, Winson Y, Cheung
Publikováno v:
Psycho-oncology. 25(12)
Prior survivorship research has largely focused on issues faced by survivors of childhood tumors, breast cancers, or hematologic malignancies. Relatively little is known about the needs of other prevalent survivor groups. Our aim was to identify the
Autor:
John R. Mackey, Maria Y Ho
Publikováno v:
Cancer Management and Research
The taxane chemotherapeutic agent docetaxel has been utilized in the management of breast cancer in the adjuvant, neoadjuvant and metastatic setting. Although well tolerated by the majority of patients, docetaxel toxicity may limit the dose which can
Autor:
Maria Y. Ho, Charles D. Blanke
Publikováno v:
Gastroenterology. 140(5)
Autor:
Maria Y. Ho, Mackey, John R.
Publikováno v:
Cancer Management & Research; 2014, Vol. 6, p253-259, 7p